Dallas, United States
Verily Health, founded in 2015, is carving a niche as a pioneering force in the Health Care technology sphere. Positioned as an Alphabet company, its ethos “We are an Alphabet company bringing the promise of precision health to everyone, every day” underscores a commitment to leveraging advanced technology for transforming healthcare delivery.
Operating at the intersection of Analytics, Enterprise Software, and Information Technology, Verily Health delivers AI-enabled precision health solutions. These endeavors enhance the utility of healthcare data across care, research, and public health. Their focus on patient-centric solutions demonstrates a commitment to making healthcare both personal and precise.
Located in the United States, Verily Health garnered significant investor confidence as evidenced by a $1.00B corporate round investment on 28 September 2022, led by Swiss Re Corporate Solutions. This underscores investor faith in Verily's strategic vision and growth potential within the rapidly evolving healthcare technology landscape.
IPRO